ASB2 and neoplasm: We found that, in concordance with the results observed in our TET2 KO models and in contrast to our observations in the TCGA dataset, methylation of the ASB2 promoter region was significantly increased in tumor samples as compared to normal (p = 0.04067, paired Wilcoxon signed-rank test, Fig. 7).